Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combining targeted DNA repair inhibition and immune-oncology approaches for enhanced tumor control
Kyle Concannon, Benjamin B. Morris, Carl M. Gay, et al.
Molecular Cell (2023) Vol. 83, Iss. 5, pp. 660-680
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Targeting the BRCA1/2 deficient cancer with PARP inhibitors: Clinical outcomes and mechanistic insights
Ashwin Ragupathi, Manrose Singh, Alexis M. Perez, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 53
Progesterone Enhances Niraparib Efficacy in Ovarian Cancer by Promoting Palmitoleic-Acid-Mediated Ferroptosis
Nayiyuan Wu, Xiu Zhang, Chao Fang, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 11
Radiotherapy-sensitized cancer immunotherapy via cGAS-STING immune pathway by activatable nanocascade reaction
Honglei Hu, Shuting Zheng, Chenxi He, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Senataxin and R-loops homeostasis: multifaced implications in carcinogenesis
Veronica Gatti, Sara De Domenico, Gerry Melino, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 14
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer
Caterina De Rosa, Francesca Iommelli, Viviana De Rosa, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 809-809
Open Access | Times Cited: 5
PRMT1 inhibition perturbs RNA metabolism and induces DNA damage in clear cell renal cell carcinoma
Joseph Walton, Angel Sau Ni Ng, Karen Arevalo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Metformin as an immunomodulatory agent in enhancing head and neck squamous cell carcinoma therapies
Wenting Li, Naiming Liu, Mingwei Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189262-189262
Closed Access
Epigenomic Echoes—Decoding Genomic and Epigenetic Instability to Distinguish Lung Cancer Types and Predict Relapse
Anke Baumann, Zholdas Buribayev, Olaf Wolkenhauer, et al.
Epigenomes (2025) Vol. 9, Iss. 1, pp. 5-5
Open Access
Combining photodynamic therapy and ATM inhibition using modified bovine serum albumin: A co-delivery nano platform for eliciting pyroptosis and apoptosis to fuel TNBC therapy
Yuao Feng, Zeliang Wu, Hui Liu, et al.
International Journal of Biological Macromolecules (2025), pp. 142140-142140
Closed Access
Radiotherapy-derived engineered stem cell exosomes improve anti-glioma immunotherapy by promoting the formation of tertiary lymphoid structure and improve the release of type I interferon
Man Li, Lisen Lu, Qiyuan Bao, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Targeting KMT5C Suppresses Lung Cancer Progression and Enhances the Efficacy of Immunotherapy
Yunfeng Yuan, Qianyu Li, Guoquan Yan, et al.
Advanced Science (2025)
Open Access
Excision Repair Cross Complementation Group 1 gene exon 3 skipping isoform presents selective cGAS-STING activation in Platinum-sensitive lung adenocarcinoma
Liuli Li, Mingyang Xiao, Liang Zhang, et al.
Free Radical Biology and Medicine (2025)
Closed Access
DNA damage repair and cancer immunotherapy
Zhiyuan Xiang, Hao Liu, Ying Hu
Genome Instability & Disease (2023) Vol. 4, Iss. 4, pp. 210-226
Closed Access | Times Cited: 9
Relationship between homologous recombination deficiency and clinical features of breast cancer based on genomic scar score
Cong Feng, Yinbin Zhang, Fei Wu, et al.
The Breast (2023) Vol. 69, pp. 392-400
Open Access | Times Cited: 9
DNA as the main target in radiotherapy—a historical overview from first isolation to anti-tumour immune response
Benjamin Frey, Kerstin Borgmann, Tina Jost, et al.
Strahlentherapie und Onkologie (2023) Vol. 199, Iss. 12, pp. 1080-1090
Closed Access | Times Cited: 9
DNA damage stress control is a tLT- and EHMT2-dependent central feature of Merkel Cell Carcinoma
Kamel Bachiri, Diala Kantar, Estelle Laurent, et al.
Journal of Investigative Dermatology (2024) Vol. 145, Iss. 2, pp. 400-410.e4
Open Access | Times Cited: 2
Multifaceted roles of cGAS-STING pathway in the lung cancer: from mechanisms to translation
Mingming Wei, Qingzhou Li, Shengrong Li, et al.
PeerJ (2024) Vol. 12, pp. e18559-e18559
Open Access | Times Cited: 2
Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genes
Teng Xu, Tianshu Yang, Baowen Yuan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Chemotherapeutic agents and leucine deprivation induce codon-biased aberrant protein production in cancer
Adva Kochavi, Remco Nagel, Pierre-René Körner, et al.
Nucleic Acids Research (2024)
Open Access | Times Cited: 1
DNA repair deficiency and the immune microenvironment: A pathways perspective
Yuzhen Zhou, Kent W. Mouw
DNA repair (2023) Vol. 133, pp. 103594-103594
Open Access | Times Cited: 3
Combining PARP Inhibition and Immunotherapy in BRCA-Associated Cancers
Geoffrey I. Shapiro, Suzanne Barry
Cancer treatment and research (2023), pp. 207-221
Closed Access | Times Cited: 2
Biophysical significance of fluorescence spectroscopy in deciphering nucleic acid dynamics: From fundamental to recent advancements
Vivek Pandey, Tejasvi Pandey
Biophysical Chemistry (2024) Vol. 316, pp. 107345-107345
Closed Access
RNA sensing induced by chromosome missegregation augments anti-tumor immunity
Nobunari Sasaki, Mizuki Homme, Takahiko Murayama, et al.
Molecular Cell (2024)
Closed Access
PRMT1 is a critical dependency in clear cell renal cell carcinoma through its role in post-transcriptional regulation of DNA damage response genes
Joseph Walton, Angel SN Ng, Karen Arevalo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Poly (ADP-ribose) Polymerase Inhibitors in Patients with Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials
Chao Zheng, Zefeng Wang, Le Li, et al.
Medicina (2023) Vol. 59, Iss. 12, pp. 2198-2198
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top